Form 4 for ABT Abbott Laboratories
Accepted 2022-03-10 00:00:00 ET · period of report 2022-03-08 · accession 0001415889-22-002844 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-10 | 2022-03-08 | ABT | DALE MICHAEL D | SVP | S - Sale | $117.00 | -4,000 | 41.8K | -9% | -$468.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2022-03-08 | S | D | 4,000 | $117.00 | 41,780 | D | — | — |